Corticosteroids Market Outlook Highlights The Next Major Growth Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Corticosteroids Market Forecast: What Market Value Is Expected By 2030?
The corticosteroids market has experienced robust expansion in recent years, with projections indicating an increase from $5.93 billion in 2025 to $6.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.7%. This past growth has been driven by several key factors, including the growing incidence of asthma and allergic conditions, the well-documented therapeutic effectiveness of corticosteroids, their extensive use in hospital settings for steroid-based treatments, heightened awareness surrounding the management of inflammatory diseases, and a broadening of pharmaceutical production capabilities.
The corticosteroids market is projected to experience significant growth over the coming years. By 2030, the market value is anticipated to reach $8.34 billion, expanding at a compound annual growth rate (CAGR) of 7.1%. Several factors are set to fuel this expansion during the forecast period, including the rising prevalence of autoimmune and respiratory conditions, the creation of safer steroid products, an increasingly elderly global population, improved healthcare availability in developing nations, and heightened funding for corticosteroid research. Among the key developments shaping this period are the emergence of targeted corticosteroid preparations, adoption of low-dose and short-duration treatment regimens, increased usage of topical and inhaled steroids, bronchodilator combination therapies, and growing application in acute respiratory care.
Download A Free Sample Report For Comprehensive Market Insights:
Corticosteroids Market Growth Drivers: What Factors Are Accelerating Expansion?
The corticosteroid market is expected to expand in the coming years, driven by the growing need for cancer therapies. Cancer treatment includes a range of approaches like surgery, chemotherapy, radiation, immunotherapy, and targeted therapies, all aimed at destroying cancer cells and reducing symptoms. This rising demand is fueled by factors such as higher cancer rates, increased awareness and screening, better healthcare access, and the availability of supportive care services. Corticosteroids improve patient outcomes by easing symptoms and making cancer treatments more tolerable, which in turn supports the growing need for comprehensive cancer care. For example, in May 2024, the UK’s National Health Service (NHS) reported that treatment activity hit an all-time high, with over 1,400 patients starting cancer treatment each working day. From April 2023 to March 2024, nearly 340,000 people received their first cancer treatment. Thus, the increasing demand for cancer treatment is driving growth in the corticosteroid market.
Corticosteroids Market Segmentation Trends And Revenue Drivers
The corticosteroids market covered in this report is segmented –
1) By Product: Glucocorticoids, Mineralocorticoids
2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications
3) By End User: Hospitals, Clinics, Research Institutes, Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids
Corticosteroids Market Trends: What Is Shaping Future Industry Growth?
Major players within the corticosteroids industry are focusing on creating advanced solutions like rescue medications to serve a broader audience, boost sales, and enhance revenue streams. Rescue medication is defined as a treatment administered to deliver fast and immediate relief from acute, severe symptoms or a sudden worsening of a chronic condition. As an example, in January 2023, the UK-based pharmaceutical firm AstraZeneca PLC obtained FDA clearance for Airsupra (albuterol/budesonide). A notable feature of this product is that it represents the first pressurized metered-dose inhaler (pMDI) of its kind, functioning as a fixed-dose combination rescue medication. It combines albuterol, a short-acting beta2-agonist (SABA), with budesonide, an inhaled corticosteroid (ICS) that possesses anti-inflammatory properties. This medication is approved for use in individuals who are 18 years and older and may be taken as needed to address or prevent bronchoconstriction. Additionally, it aids in decreasing the likelihood of asthma attacks. This combination is currently accessible in the United States and is being advanced by AstraZeneca in partnership with Avillion.
Corticosteroids Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.
Access The Complete Corticosteroids Market Report:
Corticosteroids Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
